Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Gallagher

Showing results (181-190 of 189) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 189 results.
Journal of the American Society of Nephrology : JASN|June 19, 2026
Comparing Catheters to Fistulas in Older Patients Starting Hemodialysis (ACCESS HD)Robert R Quinn, Matthew J Oliver, Ron Wald, et al.
Journal of the American Society of Nephrology : JASN|July 13, 2022
Optimizing the Design and Analysis of Future AKI TrialsMatthieu Legrand, Sean M Bagshaw, Jay L Koyner, et al.
Kidney Medicine|July 26, 2023
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and CanadaJeffrey T Ha, Anish Scaria, Jason Andrade, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2023
Airborne observations over the North Atlantic Ocean reveal the importance of gas-phase urea in the atmosphereEmily Matthews, Thomas J Bannan, M Anwar H Khan, et al.
Agronomy for Sustainable Development|April 9, 2019
Food systems for sustainable development: proposals for a profound four-part transformationPatrick Caron, Gabriel Ferrero Y de Loma-Osorio, David Nabarro, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 28, 2017
Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi SurveyNicole Evangelidis, Allison Tong, Braden Manns, et al.
Lancet (London, England)|August 16, 2025
Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trialMichael Walsh, David Collister, Martin Gallagher, et al.
American Journal of Nephrology|February 9, 2026
Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) TrialSunil V Badve, Maha Al Ammari, Craig S Anderson, et al.
JAMA|June 4, 2026
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical TrialSunil V Badve, Vlado Perkovic, Vivekanand Jha, et al.
Pageof 19

Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Journal of the American Society of Nephrology : JASN|June 19, 2026
Comparing Catheters to Fistulas in Older Patients Starting Hemodialysis (ACCESS HD)Robert R Quinn, Matthew J Oliver, Ron Wald, et al.
Journal of the American Society of Nephrology : JASN|July 13, 2022
Optimizing the Design and Analysis of Future AKI TrialsMatthieu Legrand, Sean M Bagshaw, Jay L Koyner, et al.
Kidney Medicine|July 26, 2023
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and CanadaJeffrey T Ha, Anish Scaria, Jason Andrade, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2023
Airborne observations over the North Atlantic Ocean reveal the importance of gas-phase urea in the atmosphereEmily Matthews, Thomas J Bannan, M Anwar H Khan, et al.
Agronomy for Sustainable Development|April 9, 2019
Food systems for sustainable development: proposals for a profound four-part transformationPatrick Caron, Gabriel Ferrero Y de Loma-Osorio, David Nabarro, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 28, 2017
Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi SurveyNicole Evangelidis, Allison Tong, Braden Manns, et al.
Lancet (London, England)|August 16, 2025
Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trialMichael Walsh, David Collister, Martin Gallagher, et al.
American Journal of Nephrology|February 9, 2026
Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) TrialSunil V Badve, Maha Al Ammari, Craig S Anderson, et al.
JAMA|June 4, 2026
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical TrialSunil V Badve, Vlado Perkovic, Vivekanand Jha, et al.
Pageof 19